School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Beijing Research Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
J Cell Physiol. 2019 May;234(5):7078-7089. doi: 10.1002/jcp.27462. Epub 2018 Oct 26.
Rhizoma Paridis, a traditional Chinese medicine, has shown promise in cancer prevention and therapy. Polyphyllin II is one of the most significant saponins in Rhizoma Paridis and it has toxic effects on kinds of cancer cells. However, our results in this study proved that the polyphyllin II has hepatotoxicity in vitro through caspases activation and cell-cycle arrest. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide results indicated polyphyllin II inhibited proliferation, induced apoptosis in HepaRG cells and HL-7702 cells and showed a concentration and time-dependent. Then, we selected the innovative cell model-HepaRG cells to explore the mechanism of hepatotoxicity. Our data showed the reactive oxygen species (ROS) increased and the mitochondrial membrane potential decreased in HepaRG cells after administration of polyphyllin II. Besides, with the increase of concentration, the release of lactate dehydrogenase increased and the S phase of the cell cycle was arrested. Nevertheless, when pretreatment with antioxidant N-acetylcysteine, apoptotic cells decreased significantly, inhibited the production of ROS and improved the decrease of membrane potential in HepaRG cells. Moreover, polyphyllin II treatment increased levels of Fas, Bax, cytochrome c, activated caspase-3, -8, -9, cleaved poly(ADP-ribose) polymerase and decreased Bcl-2 expression levels. Finally, we identified two signal pathways of apoptosis induced by polyphyllin II including the death receptor pathway and the mitochondria pathway. This study confirmed the hepatotoxicity of the polyphyllin II in vitro, which has never been discovered and gave a wake-up call for the clinical application of Rhizoma Paridis.
重楼,一种传统的中药,在癌症的预防和治疗方面显示出了潜力。重楼皂苷 II 是重楼中的一种重要皂苷,对多种癌细胞具有毒性作用。然而,我们在这项研究中的结果证明,重楼皂苷 II 通过半胱天冬酶激活和细胞周期阻滞在体外具有肝毒性。3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐结果表明,重楼皂苷 II 抑制增殖,诱导 HepaRG 细胞和 HL-7702 细胞凋亡,并表现出浓度和时间依赖性。然后,我们选择创新的细胞模型 HepaRG 细胞来探讨其肝毒性机制。我们的数据显示,重楼皂苷 II 处理后 HepaRG 细胞内活性氧(ROS)增加,线粒体膜电位降低。此外,随着浓度的增加,乳酸脱氢酶的释放增加,细胞周期的 S 期被阻滞。然而,当用抗氧化剂 N-乙酰半胱氨酸预处理时,凋亡细胞明显减少,抑制了 ROS 的产生,并改善了 HepaRG 细胞中膜电位的降低。此外,重楼皂苷 II 处理增加了 Fas、Bax、细胞色素 c、激活的 caspase-3、-8、-9、多聚(ADP-核糖)聚合酶的切割和 Bcl-2 表达水平的降低。最后,我们确定了重楼皂苷 II 诱导的凋亡的两条信号通路,包括死亡受体通路和线粒体通路。这项研究证实了重楼皂苷 II 在体外的肝毒性,这是以前从未发现过的,为重楼的临床应用敲响了警钟。